SCHEMBL1985357

SCHEMBL1985357

O=C(O)c1ncccc1O.[Ir]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.61
L3MBTL1 Q9Y468 4/20 0.61
ALDH1A1 P00352 3/20 0.61
MAPT P10636 2/20 0.61
TSHR P16473 2/20 0.61
CYP3A4 P08684 1/20 0.61
ALOX15 P16050 1/20 0.61
BLM P54132 1/20 0.61
AGER Q15109 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
FTO Q9C0B1 2/20 0.56
EGLN2 Q96KS0 1/20 0.56
CYP1A2 P05177 1/20 0.53
TLR7 Q9NYK1 3/20 0.49
MYC P01106 1/20 0.49
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 3/20 0.46
ALOX12 P18054 1/20 0.46
KDM6B O15054 1/20 0.46
KDM6A O15550 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15312235 0.98 KDM4E (0.63) KDM4EL3MBTL1ALDH1A1MAPTTSHR
SCHEMBL31356480 0.98 KDM4E (0.63) KDM4EL3MBTL1ALDH1A1MAPTTSHR
SCHEMBL78249 0.98 KDM4E (0.63) KDM4EL3MBTL1ALDH1A1MAPTTSHR
SCHEMBL28865462 0.96 KDM4E (0.61) KDM4EL3MBTL1ALDH1A1MAPTTSHR
SCHEMBL28111193 0.96 KDM4E (0.61) KDM4EL3MBTL1ALDH1A1MAPTTSHR
Ammonia Solution, Strong SCHEMBL14917698 0.96 KDM4E (0.61) KDM4EL3MBTL1ALDH1A1MAPTTSHR
SCHEMBL28272476 0.96 KDM4E (0.61) KDM4EL3MBTL1ALDH1A1MAPTTSHR
SCHEMBL2273367 0.96 KDM4E (0.61) KDM4EL3MBTL1ALDH1A1MAPTTSHR
SCHEMBL28568937 0.96 KDM4E (0.61) KDM4EL3MBTL1ALDH1A1MAPTTSHR
SCHEMBL2277608 0.96 KDM4E (0.61) KDM4EL3MBTL1ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102227439-B Complex salt BASF SE (DE) 2015-08-19 CN disclosed
US-8734963-B2 Complex salts BASF SE (DE) 2014-05-27 US disclosed
EP-2337786-B1 COMPLEX SALTS BASF SE (DE) 2013-08-14 EP disclosed
CN-102227439-A Complex salts BASF SE 2011-10-26 CN disclosed
US-20110177630-A1 COMPLEX SALTS BASF SE (DE) 2011-07-21 US disclosed
EP-2337786-A1 COMPLEX SALTS BASF SE (DE) 2011-06-29 EP disclosed
WO-2010037667-A1 COMPLEX SALTS BASF SE (DE) 2010-04-08 WO disclosed
CN-100487008-C Phosphorescent compound, a phosphorescent composition and an organic light-emitting device JAPAN BROADCASTING CORP SHOWA (JP) 2009-05-13 CN disclosed
CN-1547597-A Phosphorescent compound, a phosphorescent composition and an organic light-emitting device �ձ�����Э�� 2004-11-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177630-A1 COMPLEX SALTS NCLN, AP3M1, AP2M1 KDM4E 3981/4885L3MBTL1 1948/4885ALDH1A1 3608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.